首页> 美国卫生研究院文献>The Journal of Experimental Medicine >Plasmin inhibitor interactions. The effectiveness of alpha2-plasmin inhibitor in the presence of alpha2-macroglobulin
【2h】

Plasmin inhibitor interactions. The effectiveness of alpha2-plasmin inhibitor in the presence of alpha2-macroglobulin

机译:纤溶酶抑制剂相互作用。在存在α2-巨球蛋白的情况下α2-纤溶酶抑制剂的有效性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

alpha2-Plasmin inhibitor and alpha2-macroglobulin were allowed to compete for the protease plasmin. The binding of the enzyme to these inhibitors was assessed by two different but comparable methods. The interactions were completed in 10 s of incubation, and transfer of plasmin from one inhibitor to the other did not occur. Almost as much plasmin was bound to alpha2-plasmin inhibitor in mixtures containing a large molar excess of alpha2-macroglobulin relative to plasmin or alpha2-plasmin inhibitor, as was bound in mixtures not containing alpha2-macroblobulin. These studies demonstrate directly the effectiveness of alpha2-plasmin inhibitor in binding and inhibiting plasmin in the presence of alpha2-macroglobulin, and suggest that the alpha2-plasmin inhibitor may be the major circulating plasmin inhibitor.
机译:允许α2-纤溶酶抑制剂和α2-巨球蛋白竞争蛋白酶纤溶酶。通过两种不同但可比较的方法评估了酶与这些抑制剂的结合。孵育10 s后完成了相互作用,并且未发生纤溶酶从一种抑制剂转移到另一种的情况。相对于纤溶酶或α2-纤溶酶抑制剂,在含有大量摩尔过量的α2-巨球蛋白的混合物中,与纤溶酶结合的α-纤溶酶抑制剂几乎与不含α2-巨球蛋白的混合物中的纤溶酶结合。这些研究直接证明了在α2-巨球蛋白存在下α2-纤溶酶抑制剂在结合和抑制纤溶酶方面的有效性,并表明α2-纤溶酶抑制剂可能是主要的循环纤溶酶抑制剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号